CN1284599C - Medicine for treating tumor and its preparation process - Google Patents
Medicine for treating tumor and its preparation process Download PDFInfo
- Publication number
- CN1284599C CN1284599C CN 200410013406 CN200410013406A CN1284599C CN 1284599 C CN1284599 C CN 1284599C CN 200410013406 CN200410013406 CN 200410013406 CN 200410013406 A CN200410013406 A CN 200410013406A CN 1284599 C CN1284599 C CN 1284599C
- Authority
- CN
- China
- Prior art keywords
- medicine
- anlv
- artemisia
- tumor
- detumescence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 45
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 229940079593 drug Drugs 0.000 title description 9
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 239000002775 capsule Substances 0.000 claims abstract description 6
- 235000003826 Artemisia Nutrition 0.000 claims description 15
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 15
- 244000030166 artemisia Species 0.000 claims description 15
- 235000009052 artemisia Nutrition 0.000 claims description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 230000008961 swelling Effects 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 244000025254 Cannabis sativa Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 5
- 206010046798 Uterine leiomyoma Diseases 0.000 abstract description 3
- 206010006187 Breast cancer Diseases 0.000 abstract description 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 2
- 244000141218 Alpinia officinarum Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 201000007983 brain glioma Diseases 0.000 abstract 1
- 208000035269 cancer or benign tumor Diseases 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 206010044565 Tremor Diseases 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 208000032612 Glial tumor Diseases 0.000 description 1
- 206010018338 Glioma Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000005740 tumor formation Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a medicine for removing tumors and a preparation process thereof. According to a certain proportion, the Chinese medicine is prepared from five raw materials: Baonianghao, coccyx, cyperi rhizoma, Chinese date and ginger. The preparation process comprises that the five raw materials are added with water and are boiled twice; two filtered liquids are blended together, and then, are concentrated, deposited and cooled until a paste is formed; after being dried, the paste is made into granules, tablets or capsules. The medicine has better effects on curing broad-spectrum neoplasm, especially hysteromyoma, mammary cancer and brain gliomas, and has the advantages of no toxin, safety, no side effect and low cost.
Description
Technical field
The present invention relates to the Chinese herbal medicine is the detumescence tumor medicament that feedstock production forms, and specifically a kind of broad spectrum type is treated the Chinese medicine and the preparation technology thereof of multiple benign tumor or combined with chemotherapy adjuvant therapy of malignant tumor.
Background technology
Before the present invention proposed, the medicine of treatment tumor was various and assorted.But, because people are shallow for the mechanism understanding that tumor forms, often can not execute to the ill and control, the final something lost best opportunity of having missed treatment.For example, gynaecopathia such as the women easily suffers from breast cancer, hysteromyoma, general patient in the early stage the stage all take the medicine of BAIXIAO DAN and so on, and this class medicine lacks the thing of broken severe pathogenic cold in forming, its effect is not satisfactory.Because, the formation of tumor.How to be stopped up by severe pathogenic cold by ying-qi stagnant, add Yuanyang lose empty, must not temperatureization, faint and be to become, send out and be heavily fortified point extremely.
Summary of the invention
The objective of the invention is mechanism, and propose a kind of safety non-toxic, determined curative effect, and the Chinese medicine and the preparation technology thereof of detumescence tumor with low cost at tumor formation.By the detumescence tumor Chinese medicine of this prepared, can not only in time adjust patient's negative and positive, and dispelling the stagnated QI invigorates blood circulation, the power of cutting heavily fortified point is very strong, really reaches negative and positive and transfers, ice cold transformation, the pharmacological effect that hard person cuts.
In order to realize purpose of the present invention, the theoretical and practice according to medical knowledge in China, what think tumor is sick, how to be stopped up stagnantly by severe pathogenic cold, lose empty and difficult severe pain how nothing more than yang blood and qi by ying-qi, if study carefully its pain because of, as far back as interior through lifting pain opinion Ceng Yun: Supreme Being's day: " be willing to well-known figure's the five internal organs soldier pain, what gas makes so ", qi uncle day: " passages through which vital energy circulates is popular more than; ring week is endlessly; cold go into through and check late tears and not all right, visitor's insufficiency of blood outside arteries and veins; visitor's flow of QI being obstructed then in arteries and veins, so yet bitterly complete ".Cause for tumor, Ling Shu Miraculous Pivot or Divine Axis all kinds of diseases and ailments beginning gives birth to: " the long-pending beginning gives birth to; it is living must trembling with fear, and fainting, it is long-pending to be into " for therapeutic scheme of the present invention, the inventor thinks that " treating cold syndrome with hot-nature drugs; treating heat syndrome with cold-natured drugs; mild disease should be treated by routine treatment, severe disease with pseudo-symptoms should be treated with drugs similar to pseudo-symptoms in mature, hard masses should be resolved gradually " is by these five rules, the present invention is from the Chinese herbal medicine treasure-house, filter out the removing blood stasis therapeutic method to keep the adverse QI flowing downwards, sweet cold promoting the circulation of QI resolving depression, sweet gentle negative and positive transfer battalion to defend, arduous tepor is removed the five internal organs congestion, hot tepor is sent out and is played cold removing and middle expectorant Nantural non-toxic Chinese crude drug carries out prescription, make it collaborative and play a role, detumescence tumor effect is fairly obvious.
The medicine of a kind of tumor of subsiding a swelling proposed by the invention is the medicament that is prepared from by following materials of weight proportions:
Artemisia 10～35 ANLV 5～25 Rhizoma Cyperi 5～25 Fructus Jujubaes 1～10 Rhizoma Zingiberis Recens 1～8
The preferred weight proportioning of the raw material of preparation medicament of the present invention is:
Artemisia 15～25 ANLV 10～20 Rhizoma Cyperi 10～20 Fructus Jujubaes 1～8 Rhizoma Zingiberis Recens 1～5
The optimum weight proportioning of the raw material of preparation medicament of the present invention is:
Artemisia 20 ANLV 15 Rhizoma Cyperi 15 Fructus Jujubaes 5 Rhizoma Zingiberis Recenss 2
Medicament of the present invention can be a said dosage form on any pharmaceutics, the electuary of selecting for use usually, tablet or capsule.The subside a swelling preparation technology of tumor Chinese medicine of the present invention is: by above-mentioned weight proportion, artemisia, ANLV are got the cutting of herb airing, Rhizoma Cyperi is fried fragrant in iron pan, Rhizoma Zingiberis Recens is smash juice to be poured into to soak in the ANLV and closes, add Fructus Jujubae again, at last frying pan is put in above-mentioned 5 kinds of raw materials mixing and decocted twice, the decocting that at every turn adds 5～8 times of raw material weights boiled 60～90 minutes, merged filtrate twice.Concentrate then, precipitate with ethanol, be cooled to paste.Again paste is carried out making electuary, tablet or capsule after the dried.
The present invention subside a swelling tumor Chinese medicine aspect such as clinical effectiveness, pharmacology, toxicity, pharmacy research and facts have proved: the present invention is in clinical, the electuary that test group 50 examples adopt this medicine to make is taken, every day three times, one time one bag, every bag 10 grams, contrast groups adopts BAIXIAO DAN to take every day three times, each 10 grams, the contrast test time all is two months.
Clinical test results is seen the example table.
The example table: the treatment hysteromyoma is taken Chinese medicine of the present invention and is taken the clinical comparison of BAIXIAO DAN
| Case load | Basic cure (%) | Alleviate (%) | Obviously progressive (%) | Invalid (%) | Total effective rate (%) | |
| Test group | 50 | 17 examples 34% | 15 examples 30% | 14 examples 28% | 4 examples 8% | 92％ |
| Contrast groups | 7 | 0 example | 2 examples 28.57% | 2 examples 28.57% | 3 examples 42.86% | 57.14％ |
As can be seen from Table 1, the every contrast of test group obviously is better than contrast groups.
5 kinds of raw materials of detumescence tumor medicine of the present invention are principal agent with the artemisia, and ANLV is an accessory drugs, and Rhizoma Cyperi is a minister, and Fructus Jujubae and Rhizoma Zingiberis Recens make for assistant.According to Chinese medicine the dictionary record is arranged greatly, any equal avirulence is safe and reliable in 5 kinds of raw materials.
Superiority of the present invention is: this medicament is nontoxic, the perfume (or spice) that disappears, have no side effect, and it can be realized:
One, the tumor that contracts that directly disappears.
Two, ordinary person takes and can eliminate the potential tumor of human body source.
Three, with chemotherapeutics share the treatment malignant tumor remarkable.
If four, the cerebral glioma operation adds this medicine and can avoid recurrence.
Five, tumor patient is taken short-term in advance and can be distinguished that it is very pernicious.
The present invention thinks on pathology and pharmacology: tumor for sick, how to be stopped up by severe pathogenic cold by ying-qi stagnant, add Yuanyang lose empty, must not temperatureization, faint and be to become, send out and be heavily fortified point extremely.If this moment, negative and positive were adjusted, then can not cause harm and become benign tumor, benign tumor is if the people can not correct Yuanyang to lose emptyly, and then carrying out property cancerates again.In case cancerate, then produce corresponding different symptom with its each position, but generally speaking, empty and the difficult severe pain how of pudendum yang-energy anemia not, if study carefully its pain because of, as far back as interior through lifting pain opinion Ceng Yun: the Supreme Being says: " being willing to well-known figure's the five internal organs soldier pain; what gas makes so ", qi uncle says: " passages through which vital energy circulates is popular more than, ring week endlessly, cold go into through and he checks pain; tears and not all right; visitor's insufficiency of blood outside arteries and veins, visitor's flow of QI being obstructed then in arteries and veins, so yet the soldier bitterly." for the cause of tumor, Ling Shu Miraculous Pivot or Divine Axis all kinds of diseases and ailments beginning gives birth to: " the long-pending beginning gives birth to, and it is living must trembling with fear, and fainting, it is long-pending to be into." for therapeutic scheme: through cloud " treating cold syndrome with hot-nature drugs, treating heat syndrome with cold-natured drugs, mild disease should be treated by routine treatment, severe disease with pseudo-symptoms should be treated with drugs similar to pseudo-symptoms in mature, hard masses should be resolved gradually." by artemisia, Rhizoma Cyperi, ANLV, Rhizoma Zingiberis Recens, compositions such as Fructus Jujubae, its power of cutting heavily fortified point is very strong.The hot temperature of right artemisia, dispelling the stagnated QI is invigorated blood circulation, the sweet cold promoting the circulation of QI resolving depression of Rhizoma Cyperi, the hot temperature of the ANLV the five internal organs blood stasis of dispelling, the sweet temperature of Rhizoma Zingiberis Recens Fructus Jujubae, regulate yin-yang and Ying Wei, so then negative and positive are transferred, the ice cold transformation, hard person cuts, so with square person because of being subjected to the enlightenment of physical phenomenon, such as frozen food, should allow room temperatureization for well, must be undesirable if high temperature thaws, so it is we are many with hot temperature, attached hot without osmanthus, and stagnant hard the amassing of its heap soil or fertilizer over and around the roots must be with the product of promoting the circulation of QI removing blood stasis, practice for many years, and it is very good to be used for the patient.
The specific embodiment
The preparation technology of the medicine of detumescence tumor of the present invention is described in further detail below in conjunction with specific embodiment:
Embodiment 1: take by weighing raw material (kilogram) by following weight proportion
Artemisia 20 ANLV 15 Rhizoma Cyperi 15 Fructus Jujubaes 5 Rhizoma Zingiberis Recenss 2
Embodiment 2: take by weighing raw material (kilogram) by following weight proportion
Artemisia 15 ANLV 10 Rhizoma Cyperi 10 Fructus Jujubaes 3 Rhizoma Zingiberis Recenss 1
Embodiment 3: take by weighing raw material (kilogram) by following weight proportion
Artemisia 35 ANLV 25 Rhizoma Cyperi 25 Fructus Jujubaes 8 Rhizoma Zingiberis Recenss 3
Its preparation technology
Press the weight proportion of the foregoing description, artemisia, ANLV are got the cutting of herb airing, Rhizoma Cyperi is fried fragrant in iron pan, Rhizoma Zingiberis Recens is smash juice to be poured into to soak in the ANLV and closes, add Fructus Jujubae again, at last frying pan is put in above-mentioned 5 kinds of raw materials mixing and decocted twice, the decocting that at every turn adds 6 times of raw material weights boiled 75 minutes, merged filtrate twice.Concentrate then, precipitate with ethanol, be cooled to paste.Again paste is carried out making electuary after the dried tablet or capsule.
The subside a swelling medicine of tumor of the present invention, in general, for the dissolved granule of every bag 10 grams, adult every day three times, each bubble is used warm water delivery service, and three months is a course of treatment.This medicament is also very effective to brain matter tumor detumescence tumor effect.
Claims (6)
1, a kind of medicine of the pain of subsiding a swelling, it is characterized in that: it is the medicament that is prepared from by following materials of weight proportions:
Artemisia 10～35 ANLV 5～25 Rhizoma Cyperi 5～25 Fructus Jujubaes 1～10 Rhizoma Zingiberis Recens 1～8
2, the medicine of detumescence pain according to claim 1, it is characterized in that: the weight proportion of said each raw material is:
Artemisia 15～25 ANLV 10～20 Rhizoma Cyperi 10～20 Fructus Jujubaes 1～8 Rhizoma Zingiberis Recens 1～5
3, the medicine of detumescence tumor according to claim 1 is characterized in that: the weight proportion of said each raw material is:
Artemisia 20 ANLV 15 Rhizoma Cyperi 15 Fructus Jujubaes 5 Rhizoma Zingiberis Recenss 2
4, according to the medicine of claim 1 or 2 or 3 described detumescence tumors, it is characterized in that: said medicament is a said dosage form on any pharmaceutics.
5, the medicine of detumescence tumor according to claim 4 is characterized in that: said medicine city is an electuary, tablet or capsule.
6, the preparation technology of the medicine of the described detumescence tumor of a kind of claim 5, it is characterized in that: by above-mentioned weight proportion, with artemisia, ANLV is got storehouse grass airing cutting, and Rhizoma Cyperi is fried fragrant in iron pan, Rhizoma Zingiberis Recens is smash juice to be poured into to soak in the ANLV and closes, add Fructus Jujubae again, frying pan is put in above-mentioned 5 kinds of raw materials mixing decocted twice, the decocting that at every turn adds 5～8 times of raw material weights boiled 60～90 minutes, merging is carried out paste to make electuary after the dried, tablet or capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410013406 CN1284599C (en) | 2004-06-30 | 2004-06-30 | Medicine for treating tumor and its preparation process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410013406 CN1284599C (en) | 2004-06-30 | 2004-06-30 | Medicine for treating tumor and its preparation process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1593494A CN1593494A (en) | 2005-03-16 |
| CN1284599C true CN1284599C (en) | 2006-11-15 |
Family
ID=34662956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410013406 Expired - Fee Related CN1284599C (en) | 2004-06-30 | 2004-06-30 | Medicine for treating tumor and its preparation process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1284599C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104771661B (en) * | 2014-05-24 | 2018-06-08 | 王明龙 | A kind of Chinese medicine composition for treating glioma |
| CN106692906A (en) * | 2015-11-17 | 2017-05-24 | 秦皇岛乾源科技开发股份有限公司 | Tumor removal medicine and preparation process thereof |
| CN107096009A (en) * | 2017-06-28 | 2017-08-29 | 武汉厚益丹科技有限公司 | The pharmaceutical preparation of the cold-dampness that disappears tumour |
| CN107050342A (en) * | 2017-06-28 | 2017-08-18 | 武汉厚益丹科技有限公司 | The medicine and its preparation technology for the stomach neoplasm that disappears |
| CN107050418A (en) * | 2017-06-28 | 2017-08-18 | 武汉厚益丹科技有限公司 | The medicine and its preparation technology for the brain tumor that disappears |
| CN107096010A (en) * | 2017-06-28 | 2017-08-29 | 武汉厚益丹科技有限公司 | The pharmaceutical preparation for the rectal neoplasm that disappears |
| CN107158352A (en) * | 2017-07-04 | 2017-09-15 | 武汉厚益丹科技有限公司 | The medicine and its preparation technology of the gout that disappears tumour |
-
2004
- 2004-06-30 CN CN 200410013406 patent/CN1284599C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1593494A (en) | 2005-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106692906A (en) | Tumor removal medicine and preparation process thereof | |
| CN102078569B (en) | Traditional Chinese medicine preparation for treating liver cancer and preparation method thereof | |
| CN101711848B (en) | Chinese medicinal composition capable of adjunctively treating tumour | |
| CN102008650A (en) | Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof | |
| CN1284599C (en) | Medicine for treating tumor and its preparation process | |
| CN102210777B (en) | Chinese medicine composition for treating sepsis and preparation method thereof | |
| CN104857435A (en) | Chinese herbal compound composition with antineoplastic activity as well as preparation method and application thereof | |
| CN101564464B (en) | Chinese medicament for adjusting organism immunity of tumor patients | |
| CN101530580B (en) | Drug for curing ulcerative colitis | |
| CN101474388B (en) | Improved prescription of Xianchan tablet medicament and preparation method thereof | |
| CN104825922B (en) | Chinese medicine composition with anti-colorectal carcinoma activity and its preparation method and application | |
| CN104857436A (en) | Chinese herbal compound composition with anti-hepatoma activity as well as preparation method and application of Chinese herbal compound composition | |
| CN116115714B (en) | Anti-tumor Chinese medicine composition and its preparation method and application | |
| CN104027719A (en) | Traditional Chinese medicine compound composition capable of treating hypersplenism liver-depression and spleen-deficiency type diseases caused by infectious endocarditis and preparation method thereof | |
| CN105434739A (en) | Traditional Chinese medicine composition for treating chalazia and preparation method thereof | |
| CN1537559A (en) | Traditional Chinese medicine for treating AIDS | |
| CN102526248B (en) | Traditional Chinese medicine prescription capable of curing diabetes wound fester and continuously reducing blood sugar | |
| CN102631506B (en) | Traditional Chinese medicine composition capable of improving immunity and resisting fatigue | |
| CN102940753A (en) | Pills for treating glaucoma and preparation method | |
| CN1122523C (en) | Medicine for curing malignant tumor and its preparation method | |
| CN106138514A (en) | A kind of Chinese medicine composition treating intermingled phlegm and blood stasis type hypertension and preparation method thereof | |
| CN105832946A (en) | Medicine for treating human cancer and production method thereof | |
| CN106138421A (en) | Chinese medicine composition for the treatment of enteritis and preparation method and application | |
| KR20170120375A (en) | Chinese medicine preparation | |
| CN104840716A (en) | Traditional Chinese medicine composition capable of resisting breast cancer activity and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20061115 |